STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,030 | -62.9% | 11,175 | 0.0% | 0.00% | – |
| Q2 2023 | $118,790 | -94.0% | 11,175 | -86.4% | 0.00% | -100.0% |
| Q4 2021 | $1,977,000 | -6.3% | 82,407 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $2,109,000 | -28.3% | 82,879 | -5.1% | 0.00% | -33.3% |
| Q2 2021 | $2,941,000 | +30.0% | 87,356 | +49.9% | 0.01% | +20.0% |
| Q1 2021 | $2,263,000 | -45.4% | 58,264 | -12.9% | 0.01% | -37.5% |
| Q4 2020 | $4,145,000 | -9.7% | 66,913 | -51.2% | 0.01% | -20.0% |
| Q3 2020 | $4,589,000 | +33.8% | 137,016 | -4.8% | 0.01% | +25.0% |
| Q2 2020 | $3,429,000 | – | 143,905 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |